A Drive-through Simulation Tool for Mass Vaccination during COVID-19 Pandemic.
COVID-19
agent-based simulation
discrete event simulation
drive-through
mass immunization
mass vaccination
point of dispensing
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
09 Nov 2020
09 Nov 2020
Historique:
received:
05
10
2020
revised:
29
10
2020
accepted:
02
11
2020
entrez:
13
11
2020
pubmed:
14
11
2020
medline:
14
11
2020
Statut:
epublish
Résumé
Several research and development teams around the world are working towards COVID-19 vaccines. As vaccines are expected to be developed and produced, preparedness and planning for mass vaccination and immunization will become an important aspect of the pandemic management. Mass vaccination has been used by public health agencies in the past and is being proposed as a viable option for COVID-19 immunization. To be able to rapidly and safely immunize a large number of people against SARS-CoV-2, different mass vaccination options are available. Drive-through facilities have been successfully used in the past for immunization against other diseases and for testing during COVID-19. In this paper we introduce a drive-through vaccination simulation tool that can be used to enhance the planning, design, operation, and feasibility and effectiveness assessment of such facilities. The simulation tool is a hybrid model that integrates discrete event and agent-based modeling techniques. The simulation outputs visually and numerically show the average processing and waiting times and the number of cars and people that can be served (throughput values) under different numbers of staff, service lanes, screening, registration, immunization, and recovery times.
Identifiants
pubmed: 33182336
pii: healthcare8040469
doi: 10.3390/healthcare8040469
pmc: PMC7711491
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Surg. 2020 Sep;81:122-129
pubmed: 32687873
Curr Top Microbiol Immunol. 2006;304:131-52
pubmed: 16989268
J Public Health Manag Pract. 2005 Nov-Dec;11(6):542-9
pubmed: 16224290
BMC Public Health. 2011 Feb 25;11 Suppl 1:S4
pubmed: 21356133
Disaster Med Public Health Prep. 2009 Dec;3 Suppl 2:S121-31
pubmed: 19797960
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10935-40
pubmed: 12118122
Int J Environ Res Public Health. 2020 Apr 16;17(8):
pubmed: 32316165
Res Vet Sci. 2020 Aug;131:21-23
pubmed: 32278960
JAMA. 2020 Jun 23;323(24):2458-2459
pubmed: 32421155
Am J Infect Control. 2020 Jun;48(6):731-732
pubmed: 32305432
Ann Emerg Med. 2010 Mar;55(3):268-73
pubmed: 20079956
Med Decis Making. 2002 Sep-Oct;22(5 Suppl):S17-25
pubmed: 12369227
Public Health Rep. 2014;129 Suppl 4:145-53
pubmed: 25355986
J Public Health Manag Pract. 2006 Jul-Aug;12(4):365-72
pubmed: 16775534
Res Social Adm Pharm. 2021 Jan;17(1):1920-1924
pubmed: 32792322
Obstet Gynecol. 2020 Jul;136(1):29-32
pubmed: 32332322
Acad Pediatr. 2020 Aug;20(6):753-755
pubmed: 32479895
Ann Intern Med. 2020 Aug 18;173(4):308-310
pubmed: 32568575